Lupin Bets Big on Oncology in AbbVie-Partnership, Could Garner $1 Billion+, an Industrial Info Market Brief

Indian pharmaceutical company Lupin Limited is eyeing major growth in its portfolio through a Novel Drug Discovery and Development (NDDD) program, focused on oncology, immunology and metabolic disorders

Subscribe Now!

(All Fields Required)

Fill Out Form To Subscribe +

First Name

Last Name

Email Address

Username

Password

Repeat Password

Jacobs Builds Role in Semiconductors, Healthcare as Changes ...
Japan Hosts $273 Million in Cosmetic-Related Pharma Projects
U.S. Supplement Production Brings Millions in Spending
Samsung Biologics Constructing ADC Plant in South Korea
Data Center Activity Propels Virginia to $12.7 Billion of Pr...

All Members Receive the Following Resources:

Industry News Digest
Upcoming Webinars
On-Demand Webinars
The NavigatIIR Newsletter
Economic Indicators

View All Member Resources

Lupin Bets Big on Oncology in AbbVie-Partnership, Could Garner $1 Billion+, an Industrial Info Market Brief

Login or Register for Instant Access

Subscribe Now!

Related Articles

All Members Receive the Following Resources:

Quick Links

Global Market Intelligence

Events

Resources

Industrial Info Resources